Day: January 13, 2022

Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology (MST)™ Franchise from VYNE Therapeutics, Inc.

Franchise includes AMZEEQ® for the treatment of acne and ZILXI® for the treatment of rosacea, and a development-stage dermatology program...

Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualized Neoantigen Vaccine GRANITE for First Line (1L) Maintenance Treatment of Metastatic, Microsatellite-Stable Colorectal Cancer (MSS-CRC)

Adagene Announces First Patients with Advanced Non-Small Cell Lung Cancer Dosed in Phase 1b/2 Clinical Trial of ADG106 in Combination with Nivolumab in Singapore

Clinical trial to be conducted at the National University Cancer Institute, Singapore and the National Cancer Centre Singapore, in Collaboration...

Kern Health Systems Selects CitiusTech’s FAST+ FHIR Solution to Comply with the CMS Interoperability and Patient Access Final Rule and Provide Secure, Real-Time Data Access to Members

PRINCETON, N.J.--(BUSINESS WIRE)--Kern Health Systems (KHS), known as Kern Family Health Care, is the largest health plan in Kern County,...

error: Content is protected !!